Bank of New Hampshire’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$121K Sell
2,845
-19,318
-87% -$1.05M 0.03% 243
2026
Q1
$1.39M Buy
22,163
+4
+0% +$320 0.32% 82
2025
Q4
$2.11M Buy
22,159
+523
+2% +$51.3K 0.48% 64
2025
Q3
$2.11M Buy
21,636
+1,912
+10% +$198K 0.49% 62
2025
Q2
$2.12M Buy
19,724
+16,699
+552% +$1.69M 0.53% 61
2025
Q1
$305K Buy
3,025
+460
+18% +$46.3K 0.08% 159
2024
Q4
$229K Buy
2,565
+330
+15% +$29.1K 0.06% 172
2024
Q3
$187K Buy
2,235
+770
+53% +$60.7K 0.05% 193
2024
Q2
$113K Buy
+1,465
New +$107K 0.03% 236

Other funds holding BSX

Bank of New Hampshire's BSX Position: Q2 2026 in Review

Bank of New Hampshire reduced its Boston Scientific (BSX) stake by 87% in Q2 2026, selling an estimated $1.05M and leaving 2,845 shares worth $121K. The position accounts for 0.03% of the portfolio, ranked #243.

Bank of New Hampshire first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.12M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Bank of New Hampshire held 2,845 shares of Boston Scientific worth $121K as of Q2 2026.
  • Bank of New Hampshire sold 19,318 Boston Scientific shares in Q2 2026, an estimated $1.05M.
  • Boston Scientific made up 0.03% of Bank of New Hampshire's portfolio in Q2 2026, its #243 holding.
  • Bank of New Hampshire first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
  • Bank of New Hampshire's Boston Scientific position peaked at $2.12M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.